Tenascin expression in cutaneous fibrohistiocytic tumors: Immunohistochemical investigation of 24 cases: Immunohistochemical investigation of 24 cases

American Journal of Dermatopathology

Volumn 18, Issue 5, 1996, Pages 454-459

  Franchi, Alessandro ^a   Santucci, Marco ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Atypical fibroxantoma; Benign fibrous histiocytoma; Dermatofibrosarcoma protuberans; Extracellular matrix; Fibrohistiocytic tumors; Malignant fibrous histiocytoma; Tenascin

Indexed keywords

COLLAGEN; TENASCIN;

ARTICLE; CLINICAL ARTICLE; CYTOPLASM; DERMATOFIBROMA; EXTRACELLULAR MATRIX; FIBROHISTIOCYTOMA; FIBROXANTHOMA; HISTIOCYTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT FIBROUS HISTIOCYTOMA; PRIORITY JOURNAL;

DERMATOFIBROSARCOMA; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; SKIN NEOPLASMS;

EID: 0029858918     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199610000-00002     Document Type: Article

References (40)

1. Chiquet-Ehrisman R, Mackie EJ, Pearson C, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986;47:131-9.
2. Erickson HP, Taylor HC. Hexabrachion proteins in embryonic chicken tissues and human tumors. J Cell Biol 1987;105:1387-94.
3. Crossin KL, Hoffman S, Grumet M, Thiery J-P, Edelman GM. Site-restricted expression of cytotactin during development of the chicken embryo. J Cell Biol 1986;102:1917-30.
4. Natali PG, Nicotra MR, Bigotti A, et al. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int J Cancer 1991;47:811-6.
5. Howeedy AA, Virtanen I, Laitinen L, Gould NS, Koukoulis GK, Could VE. Differential distribution of tenascin in the normal, hyperplastic and neoplastic breast. Lab Invest 1990;63:798-806.
6. Soini Y, Pääkkö P, Virtanen I, Lehto V. Tenascin in salivary gland tumours. Virchows Arch [A] 1992;421:217-22.
7. Lightner VA, Gumkowski F, Bigner DD, Erickson HP. Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy. J Cell Biol 1989;108:2483-93.
8. Stamp GWH. Tenascin distribution in basal cell carcinomas. J Pathol 1989;159:225-9.
9. Anbazhagan R, Sakakura T, Gusterson BA. The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia. Virchows Arch [B] 1990;59:59-63.
10. Natali PG, Nicotra MR, Bartolazzi A, et al. Expression and production of tenascin in benign and malignant lesions of melanocytic lineage. Int J Cancer 1990;46:586-90.
11. Murphy GF, Elder DE. Non-melanocytic tumors of the skin. In: Rosai J, ed. Atlas of tumor pathology: 3rd series, fasc 1. Washington, DC: Armed Forces Institute of Pathology, 1991:223-36.
12. Erlandson RA. Diagnostic electron microscopy of tumors. New York: Raven, 1994:367.
13. Enzinger FM, Weiss SW. Soft tissue tumors. 3rd ed. St Louis: CV Mosby, 1995:293-380.
14. Ackerman AB, Ragaz A. The lives of lesions: chronology in dermatopathology. New York: Masson, 1984:36.
15. Fletcher CDM. Angiomatoid "malignant fibrous histiocytoma": an immunohistochemical study indicative of myoid differentiation. Hum Pathol 1991;164:23-9.
16. Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992;16:213-28.
17. Mentzel T, Calonje E, Fletcher CDM. Leiomyosarcoma with prominent osteoclast-like giant cells: analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma. Am J Surg Pathol 1994;18:258-65.
18. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum Pathol 1991;22:636-43.
19. Verstraeten AA, Mackie EJ, Hageman PC, et al. Tenascin expression in basal cell carcinoma. Br J Dermatol 1992;127:571-4.
20. Soini Y, Pääkkö P, Nuorva K, et al. Tenascin immunoreactivity in lung tumors. Am J Clin Pathol 1993;100:145-50.
21. Kindblom LG, Jacobsen GK, Jacobsen M. Immunohistochemical investigations of tumors of supposed fibroblastic-histiocytic origin. Hum Pathol 1982;13:834-40.
22. Eckert F, Burg G, Braun-Falco O, Schmid U, Gloor F. Immunostaining in atypical fibroxanthoma of the skin. Pathol Res Pract 1989;184:27-34.
23. Ma CK, Zarbo RJ, Gown AM. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. Am J Clin Pathol 1992;97:478-83.
24. Soini Y. Cell differentiation in benign cutaneous fibrous histiocytomas: an immunohistochemical study with antibodies to histiomonocytic cells and intermediate filament proteins. Am J Dermatopathol 1990;12:134-40.
25. Fletcher CDM, Evans BJ, MacArtney JC, Smith N, Wilson Jones E, McKee PH. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology 1985;9:921-38.
26. Lawson CW, Fisher C, Gatter KC. An immunohistochemical study of differentiation in malignant fibrous histiocytoma. Histopathology 1987;11:375-83.
27. Silvis NG, Swanson PE, Manivel JC, Kaye VN, Wick MR. Spindle cell and pleomorphic neoplasms of the skin: a clinicopathologic and immunohistochemical study of 30 cases, with emphasis on "atypical fibroxanthomas." Am J Dermatopathol 1988;10:9-19.
28. Churg AM, Kahn LB. Myofibroblasts and related cells in malignant fibrous and fibrohistiocytic tumours. Hum Pathol 1977;8:205-18.
29. Iwasaki H, Yoshitake K, Ohjimi Y, et al. Malignant fibrous histiocytoma: proliferative compartment and heterogeneity of "histiocytic" cells. Am J Surg Pathol 1992;16:735-45.
30. Soini Y, Autio-Harmainen, Miettinen M. Immunoreactivity for laminin and type IV collagen in malignant and benign fibrous histiocytoma. J Pathol 1989;158:223-8.
31. Alguacil-Garcia A, Unni KK, Goellner JR. Histogenesis of dermatofibrosarcoma protuberans: an ultrastructural study. Am J Clin Pathol 1978;69:427-34.
32. Katenkamp D, Stiller D. Cellular composition of the so-called dermatofibroma (histiocytoma cutis). Virchows Arch [A] 1975;367:325-36.
33. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988;107:2757-67.
34. Mackie EJ, Thesleff I, Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol 1987;105:2569-79.
35. Pinkus H. Pathobiology of the pilary complex. Jpn J Dermatol (Ser B) 1967;77:304-30.
36. Inaguma Y, Kusakabe M, Mackie EJ, Pearson CA, Chiquet-Ehrisman R, Sakukura T. Induction of stromal tenascin in the mouse mammary gland: from embryogenesis to cancerogenesis. Dev Biol 1988;128:245-55.
37. Engel J. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation? FEBS Lett 1989;251:1-7.
38. Duda RB, Cundiff D, August CZ, Wagman LD, Bauer KD. Growth factor receptor and related oncogene determination in mesenchymal tumors. Cancer 1993;71:3526-30.
39. Prieto AL, Andersson-Fisone C, Crossin KL. Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin. J Cell Biol 1992;119:663-78.
40. Prieto AL, Edelman GM, Crossin KL. Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sci USA 1993;90:10,154-8.